AU2002365926A1 - Compositions and methods directed to anthrax toxin - Google Patents

Compositions and methods directed to anthrax toxin

Info

Publication number
AU2002365926A1
AU2002365926A1 AU2002365926A AU2002365926A AU2002365926A1 AU 2002365926 A1 AU2002365926 A1 AU 2002365926A1 AU 2002365926 A AU2002365926 A AU 2002365926A AU 2002365926 A AU2002365926 A AU 2002365926A AU 2002365926 A1 AU2002365926 A1 AU 2002365926A1
Authority
AU
Australia
Prior art keywords
compositions
anthrax toxin
methods directed
directed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365926A
Inventor
Richard S. Sackler
Daniel A. Soltis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of AU2002365926A1 publication Critical patent/AU2002365926A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002365926A 2001-10-25 2002-10-25 Compositions and methods directed to anthrax toxin Abandoned AU2002365926A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34684001P 2001-10-25 2001-10-25
US60/346,840 2001-10-25
PCT/US2002/034373 WO2003063768A2 (en) 2001-10-25 2002-10-25 Compositions and methods directed to anthrax toxin

Publications (1)

Publication Number Publication Date
AU2002365926A1 true AU2002365926A1 (en) 2003-09-02

Family

ID=27662958

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365926A Abandoned AU2002365926A1 (en) 2001-10-25 2002-10-25 Compositions and methods directed to anthrax toxin

Country Status (2)

Country Link
AU (1) AU2002365926A1 (en)
WO (1) WO2003063768A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8367603B2 (en) 2003-11-19 2013-02-05 Council Of Scientific And Industrial Research Protein capable of inhibiting anthrax toxin activity
US20050107295A1 (en) * 2003-11-19 2005-05-19 Naveen Arora Novel protein capable of inhibiting anthrax toxin activity
ITFI20040076A1 (en) * 2004-03-30 2004-06-30 Luisa Bracci SYNTHETIC PEPTIDES AS ANTIDOTES IN THE TOXICATION OF TOXINS DERIVED FROM THE BACTERIUM BACILLUS ANTHRACIS
WO2008042261A2 (en) * 2006-09-28 2008-04-10 Elusys Therapeutics, Inc. Anti-anthrax antibody, formulations thereof, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
KR20010015817A (en) * 1997-11-14 2001-02-26 유로-셀티큐 에스.에이. Modified Antibodies with Enhanced Ability to elicit an anti-idiotype response

Also Published As

Publication number Publication date
WO2003063768A3 (en) 2003-12-04
WO2003063768A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002361623A1 (en) Methods and compositions for chromatography
AU2002327055A1 (en) Topical compositions and methods of application
AU2002345353A1 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2002361548A1 (en) Compositions and methods for bacteria detection
AU2001233932A1 (en) Method and composition
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AUPR446801A0 (en) Novel compositions and uses therefor
AU2002366809A1 (en) Syn3 compositions and methods
AU2002365926A1 (en) Compositions and methods directed to anthrax toxin
AU2002239775A1 (en) Chemical-library composition and method
AU2002332507A1 (en) Levothyroxine compositions and methods
AU2003268078A1 (en) Levothyroxine compositions and methods
AU2002359869A1 (en) Pak5-related compositions and methods
AU2000251520A1 (en) Antiviral methods and compositions
AU2001249194A1 (en) Immunokine composition and method
AU2002246221A1 (en) Method and composition
AU2002331660A1 (en) Supported fluridone compositions and methods
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002362468A1 (en) Levothyroxine compositions and methods
AUPR368901A0 (en) Compositions and uses therefor-ii

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase